Use of Rh Immune Globulin in First-Trimester Abortion and Miscarriage.

Abstract

Department of Women's Health, Dell Medical School, University of Texas at Austin, and the Comprehensive Fetal Care Center, Dell Children's Medical Center, Austin, Texas Financial Disclosure Dr. Moise received funding from Janssen Pharmaceuticals, Inc., paid on his behalf to Dell Medical School at the University of Texas at Austin for a clinical trial on a monoclonal antibody for the treatment of hemolytic disease of the fetus and newborn. He received royalty funding from UpToDate, Inc., for authorship on various chapters. He received consulting fees from Health Management Associates, Inc., for consultation on the formation of fetal centers, and from BillionToOne, Inc., paid on his behalf to Dell Medical School at the University of Texas at Austin. He received honoraria from GLC Healthcare, Inc., for podcast content on hemolytic disease of the fetus and newborn. Lastly, Dr. Moise serves as a non-paid consultant for Immunology for Janssen Pharmaceuticals, Inc.